Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Loma Linda University School of Medicine and Independent Medical Alliance. The Loma Linda University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Loma Linda University School of Medicine designates this Enduring Material for a maximum of 12.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
This program has been planned and implemented in accordance with ACCME Standards for Integrity and Independence. The Loma Linda University School of Medicine Office of Continuing Medical Education relies on its CME faculty to provide program content that is free of commercial bias. Therefore, in accordance with ACCME standards, any faculty and/or provider industry relationships will be disclosed and resolved.
Disclosures:
Planners
Kelly Bumann, Lynne Kristensen, Jennifer Smith, and Joseph Varon, MD, FACP, FCCP, FCCM, FRSM have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
Speakers:
Kimberly Biss, MD, Kristina Carman, ND, NT, IFM, Ryan Cole, MD, Suzanne Gazda, MD, Mollie James, DO, MPH, FACOS, FACS, IFMCP, Jan Jekielek, Paul E. Marik, MD, Kirk Milhoan, MD, Elizabeth Mumper, MD, Adylle Varon, LAC, DAcOM, L. Ac., NCCAOM DIPL.OM., Joseph Varon, MD, FACP, FCCP, FCCM, FRSM, Jordan Vaughn, MD, Jamie K. Waselenko, MD, FACP, FICT, and Josef Witt-Doerring, MD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
Mary Talley Bowden, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- The Wellness Company - Independent Contractor - Relationship Ended
Ray Page, DO, PhD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Astellas - Consulting - Relationship Ended
- Puma - Consulting - Relationship Ended
- Regeneron - Consulting - Relationship Ended
- Abbvie - Consulting - Relationship Ended
- Janssen - Consulting - Relationship Ended
- Eli Lilly - Contracted Research - Relationship Has Not Ended
- Exelixis - Contracted Research - Relationship Has Not Ended
- Incyte - Contracted Research - Relationship Has Not Ended
- Genentech - Contracted Research - Relationship Has Not Ended
- AstraZeneca - Contracted Research - Relationship Has Not Ended
- Gilead - Contracted Research - Relationship Has Not Ended
- Mirati - Contracted Research - Relationship Has Not Ended
- Seagan - Contracted Research - Relationship Has Not Ended
- GlaxoSmithKline - Contracted Research - Relationship Has Not Ended
- Hoffmann La Roche - Contracted Research - Relationship Has Not Ended
- Daiichi Sankyo - Contracted Research - Relationship Has Not Ended
- Novartis - Contracted Research - Relationship Has Not Ended
Michael Turner, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- ACTT Med - Independent Contractor - Relationship Has Not Ended
- Optavia - Independent Contractor - Relationship Has Not Ended
- Endourage - Independent Contractor - Relationship Has Not Ended
Any financial relationship that was found to be relevant has been mitigated.
Active Dates: June 3, 2026 - June 2, 2027
